Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | BCL9 | O00512 | 1/20 | 0.37 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.37 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1695769 | 0.98 | ALOX15 (0.38) | ALOX15ALDH1A1RAB9ABCL9CTNNB1 | |
| SCHEMBL1695483 | 0.98 | ALOX15 (0.38) | ALOX15ALDH1A1RAB9ABCL9CTNNB1 | |
| SCHEMBL1695767 | 0.98 | ALOX15 (0.38) | ALOX15ALDH1A1RAB9ABCL9CTNNB1 | |
| SCHEMBL1695492 | 0.95 | ALDH1A1 (0.39) | ALOX15ALDH1A1RAB9ABCL9CTNNB1 | |
| SCHEMBL3775177 | 0.89 | GSTP1 (0.37) | ALDH1A1RAB9AGSTP1CTSKHDAC4 | |
| SCHEMBL11801851 | 0.89 | NAAA (0.44) | ALOX15ALDH1A1NLRP3KMT2AKDM4E | |
| SCHEMBL7566848 | 0.87 | GSTP1 (0.36) | ALDH1A1RAB9AGSTP1CTSKHDAC4 | |
| SCHEMBL28240434 | 0.87 | NAAA (0.46) | ALOX15ALDH1A1NLRP3MAPTKMT2A | |
| SCHEMBL20210630 | 0.86 | ALDH1A1 (0.34) | ALDH1A1RAB9AGSTP1CTSKHDAC2 | |
| SCHEMBL1695435 | 0.86 | ESR1 (0.41) | ALOX15ALDH1A1RAB9AGSTP1CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582453-B1 | TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS | ECOSYNTH NV (BE) | 2016-12-28 | — | — | EP | disclosed |
| US-8865931-B2 | Transesterification process using mixed salt acetylacetonates catalysts | ECOSYNTH BVBA (BE) | 2014-10-21 | — | — | US | disclosed |
| CN-103140287-A | Transesterification process using mixed salt acetylacetonates catalysts | ECOSYNTH BVBA | 2013-06-05 | — | — | CN | disclosed |
| EP-2582453-A2 | TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS | Ecosynth BVBA (BE) | 2013-04-24 | — | — | EP | disclosed |
| US-20130090492-A1 | TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS | ECOSYNTH BVBA (BE) | 2013-04-11 | — | — | US | disclosed |
| WO-2011157645-A2 | TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS | ECOSYNTH BVBA (BE) | 2011-12-22 | — | — | WO | disclosed |
| US-20050165201-A1 | Epoxidizing an alpha-halohydrin intermediate from a halide substitution-deesterification of an alpha -hydroxy ester derivative obtained by the coupling reaction of a phenol and a glycidyl ester | BORIACK CLINTON J (US) | 2005-07-28 | — | — | US | disclosed |
| US-20030149219-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | BORIACK CLINTON J (US) | 2003-08-07 | — | — | US | disclosed |
| US-6534621-B2 | Epoxidizing an alpha-halohydrin intermediate produced from an in situ halide substitution-deesterification of an alpha-hydroxy ester derivative | DOW GLOBAL TECHNOLOGIES INC. | 2003-03-18 | — | — | US | disclosed |
| EP-1290058-A2 | PROCESS FOR MANUFACTURING A HYDROXYESTER DERIVATIVE INTERMEDIATE AND EPOXY RESINS PREPARED THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001088013-A2 | PROCESS FOR MANUFACTURING A HYDROXYESTER DERIVATIVE INTERMEDIATE AND EPOXY RESINS PREPARED THEREFROM | DOW GLOBAL TECHNOLOGIES INC (US) | 2001-11-22 | — | — | WO | disclosed |
| EP-0428343-B1 | A process for producing an alpha,beta-unsaturated carbonyl compound | NIPPON ZEON CO (JP) | 1994-05-04 | — | — | EP | disclosed |
| US-5118863-A | Process for producing an α,β-unsaturated carbonyl compound | NIPPON ZEON CO., LTD. (JP) | 1992-06-02 | — | — | US | disclosed |
| EP-0428343-A1 | A process for producing an alpha,beta-unsaturated carbonyl compound | NIPPON ZEON CO., LTD. (JP) | 1991-05-22 | — | — | EP | disclosed |
| US-4112235-A | Transesterification of carboxylic acids | UOP INC. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090492-A1 | TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS | ACACA, ACACB, ACSL6 | ALOX15 573/4885ALDH1A1 68/4885RAB9A 3866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.